Hermes Florez to Glucagon-Like Peptides
This is a "connection" page, showing publications Hermes Florez has written about Glucagon-Like Peptides.
Connection Strength
0.331
-
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial. Lancet. 2019 07 13; 394(10193):131-138.
Score: 0.166
-
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet. 2019 07 13; 394(10193):121-130.
Score: 0.166